OCT-3/4 is active in many somatic tumors, and several studies have proposed its functional importance in cervical cancer [3], TGCTs [5], prostate cancer [57], TICs [59], colon cancer [7], and breast cancer [1,61]. This evidence concerns the gene POU5F1 and breast carcinoma.